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Abstract
Objectives To compare the prevalence and management
of cardiovascular risk factors (CVRFs) between immigrant
groups and Swiss nationals.
Methods The Swiss Health Surveys (SHS, N = 49,245)
and CoLaus study (N = 6,710) were used. Immigrant
groups from France, Germany, Italy, Portugal, Spain, for-
mer Yugoslavia, other European and other countries were
defined.
Results Immigrants from Italy, France, Portugal, Spain
and former Yugoslavia presented a higher prevalence of
smoking than Swiss nationals. Immigrants reported less
hypertension than Swiss nationals, but the differences were
reduced when blood pressure measurements were used.
The prevalence of dyslipidaemia was similar between
immigrants and Swiss nationals in the SHS. When eligi-
bility for statin treatment was assessed, immigrants from
Italy were more frequently eligible than Swiss nationals.
Immigrants from former Yugoslavia presented a lower
prevalence of diabetes in the SHS, but a higher prevalence
in the CoLaus study. Most differences between immigrant
groups and Swiss nationals disappeared after adjusting for
age, leisure-time physical activity, being overweight/
obesity and education.
Conclusions Most CVRFs are unevenly distributed
among immigrant groups in Switzerland, but these differ-
ences are due to disparities in age, leisure-time physical
activity, being overweight/obesity and education.
Keywords Diabetes  Dyslipidaemia  Hypertension 
Immigrants  Smoking  Switzerland
Introduction
Immigrants tend to present a higher risk of cardiovascular
disease (CVD) than local nationals (Gadd et al. 2003), but
this statement has been challenged (Kouris-Blazos 2002).
Although part of these differences might be related to
differing levels of socioeconomic status (Bos et al. 2004),
some migrant groups have been shown to be either more
(Bainey and Jugdutt 2009) or less susceptible (Kouris-
Blazos 2002) to CVD irrespective of their risk factor levels.
Several studies have also shown that the management of
CVD risk factors (CVRFs) is less optimal among migrants
compared to nationals (Cappuccio et al. 1997; Carrasco-
Garrido et al. 2007).
Switzerland has a large immigrant community of over
1.6 million people, representing more than one-fifth of the
total population (Office Fe´de´ral des Migrations (ODM)
2010). In Switzerland, immigrants from southern European
countries present lower mortality rates from CVD than
Swiss nationals (Wanner et al. 2000). Whether these lower
CVD mortality rates among migrants in Switzerland is due
to differences in socioeconomic or CVRF levels is cur-
rently unknown. Finally, the prevalence of the main
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CVRFs (smoking, hypertension, dyslipidaemia and diabe-
tes) has not been studied with respect to immigrant groups
in Switzerland.
In this study, we used the data from two large, popula-
tion-based samples—Swiss Health Surveys and the
Cohorte Lausannoise (CoLaus) study—to assess the prev-
alence and management of CVRFs according to nationality
in Switzerland.
Methods
Two different databases (Swiss Health Survey—SHS and
CoLaus study) were used. This was because they comple-
ment each other regarding the methodology: the SHS is a
nationwide qualitative study, which collects only reported
data, while the CoLaus study is a local (city of Lausanne)
population-based quantitative study, which measures data
using standardised procedures. The use of two different
databases also enables to replicate and confirm the findings,
thus decreasing the likelihood of bias-induced results.
CoLaus study
The CoLaus Study was approved by the Institutional Ethics
Committee of the University of Lausanne. The CoLaus
Study is a cross-sectional study aimed at assessing the
prevalence and deciphering the molecular determinants of
cardiovascular risk factors in the Caucasian population of
Lausanne, Switzerland.
The sampling procedure of the CoLaus Study has been
described previously (Firmann et al. 2008). The inclusion
criteria applied were as follows: (a) written informed
consent; (b) age 35–75 years; (c) willingness to take part in
the examination and donate a blood sample; and (d) Cau-
casian origin. Recruitment began in June 2003 and ended
in May 2006. The participation rate was 41%. For this
study, data from non-Caucasian participants (n = 555),
which were initially excluded from the main study but
assessed the same way, were also included.
All participants attended the outpatient clinic of the
University Hospital of Lausanne in the morning following
an overnight fast. Data were collected by trained field
interviewers in a single visit lasting approximately 60 min.
Venous blood samples were drawn after an overnight
fast, and assays were performed by the CHUV Clinical
Laboratory on fresh plasma samples within 2 h of blood
collection in a Modular P apparatus (Roche Diagnostics,
Switzerland). LDL-cholesterol was calculated with the
Friedewald formula only if triglycerides were\4.6 mmol/L.
Blood pressure (BP) was measured three times on the
left arm after at least 10 min of rest in a seated position
using a clinically validated automated oscillometric device
(Omron HEM-907, Matsusaka, Japan) with a standard
cuff, or a large cuff if arm circumference was C33 cm. The
average of the last two BP readings was used. Measured
high blood pressure (HBP) was defined as mean systolic
BP (SBP) C140 mmHg or mean diastolic BP (DBP)
C90 mmHg, or the use of antihypertensive medication.
Reported HBP was defined as a positive answer to the
question ‘‘Have you ever been told by a doctor that you
have HBP (hypertension)?’’ Antihypertensive medication
was defined as a positive answer to the question ‘‘Are you
taking a medication/drug to treat hypertension?’’ Treated
participants were considered adequately controlled if their
SBP and DBP were below 140 and 90 mmHg, respectively.
Measured diabetes was defined as fasting plasma glu-
cose (FPG) C7 mmol/L (Anonymous 2008) and/or the
presence of oral hypoglycaemic treatment and/or insulin.
Reported diabetes was defined as a positive answer to the
question ‘‘Have you ever been told by a doctor that you
have diabetes?’’ Treated subjects were defined as those
taking oral anti-diabetic drugs and/or insulin.
The SCORE risk function for low-risk countries of the
European Society of Cardiology (Conroy et al. 2003)
recalibrated for the Swiss population (Marques-Vidal et al.
2008) was used to compute individual 10-year CVD risk.
The original SCORE function was derived from a pool of
12 European prospective studies and allows the estima-
tion of 10-year risk of fatal CVD based on gender,
blood pressure, total cholesterol and smoking status (for
more information, see http://www.heartscore.org/Pages/
welcome.aspx). Eligibility for hypolipidaemic treatment
was defined as a 10-year risk C5% or the presence of
hypolipidaemic drug treatment. Reported dyslipidaemia
was defined as a positive answer to the question ‘‘Have you
ever been told by a doctor that you have high cholesterol?’’
Because no data were available for hypolipidaemic drug
treatment among non-Caucasians, the analysis was
restricted to Caucasian participants.
Swiss Health Survey
Data from the four Swiss Health Surveys (SHS) were
obtained from the Swiss Federal Bureau of Statistics
(http://www.bfs.admin.ch). The SHS is a cross-sectional,
nationwide, population-based telephone survey conducted
every 5 years since 1992 by the Federal Statistical Office
of Switzerland under a mandate from the federal govern-
ment (Calmonte et al. 2005). To date, the survey has been
carried out four times, in 1992/93, 1997, 2002 and 2007.
As no data for hypertension and diabetes were available in
the 1992/93 survey, only data from the subsequent surveys
(1997, 2002 and 2007) were used.
The study population was chosen by stratified random
sampling of a database of all private Swiss households with
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fixed-line telephones (as opposed to mobile phones). The
first sampling stratum consisted of the seven main regions:
West ‘‘Le´man’’, West-central ‘‘Mittelland’’, northwest,
Zurich, northeastern, central and south. The second stratum
consisted of the cantons, and the number of households
drawn was proportional to the population of the canton. In
some cantons, oversampling of households was performed
to obtain accurate cantonal estimates. The third stratum
consisted of the household. One member of the household
was randomly selected in advance within all members aged
15 years and over. A letter inviting this selected household
member to participate in the survey was sent to each sam-
pled subject, who was contacted thereafter by phone and
interviewed using computer-assisted telephone interview
(CATI) software to manage dialling and data collection.
Face-to-face interviews were organised for subjects older
than 75 years. In the case of long-term absence of a sampled
subject, a proxy interviewee was requested to provide
answers on behalf of the pre-defined sampled person
(approximately 3% of households). The interviews were
carried out in German, French or Italian, as appropriate.
People who did not speak any of these three languages were
excluded from the survey. Other criteria for exclusion were
asylum seeker status, households without a fixed-line tele-
phone, very poor health status and living in a nursing home
(IHA-GfK 2003). The participation rate was 85% in 1997,
64% in 2002, and 66% in 2007. It is estimated that\2% of
households were excluded owing to these exclusion criteria.
Details are available at http://www.bfs.admin.ch/bfs/
portal/fr/index/infothek/erhebungen__quellen/blank/blank/
ess/01.html.
The prevalence of hypertension, hypercholesterolaemia
or diabetes, respectively, was considered if the participants
provided a positive answer to the questions: ‘‘Did a doctor
or a health professional tell you that you have HBP/a high
cholesterol level/diabetes?’’ Subjects were considered as
being treated for hypertension, hypercholesterolaemia or
diabetes, respectively, if they answered positively to the
questions ‘‘Are you being treated for blood pressure/to
decrease your cholesterol levels/for diabetes?’’
Other data
The following nationalities were considered: Swiss, former
Yugoslavians (Serbian, Croatian, Bosnian and Herzegov-
inan, Kosovan and Macedonian), French, German, Italian,
Portuguese and Spanish. Because of the small number of
subjects, other nationalities were grouped into either ‘‘other
Europeans’’ or ‘‘the rest of the world’’ (Bischoff and
Wanner 2008); Turkish immigrants were not categorised
because of the small sample sizes. For the CoLaus study,
country of birth was considered as the nationality, whereas
for the SHS, the participants were asked about their
nationality. The length of residence in Switzerland was
assessed in the CoLaus study, but the SHS collected such
information only for 2007.
In the CoLaus study, body weight and height were mea-
sured with participants standing without shoes in light indoor
clothes. In the SHSs, the subjects were asked about their
current body weight and height. Body mass index (BMI) was
calculated as weight divided by height2. Subjects were
considered to be normal weight, overweight or obese if the
BMI was\25, C25 and\30 and C30 kg/m2, respectively.
Three age categories were considered: 18–44, 45–64 and
C65 years. Education was categorised as follows: (1) no
education completed ? primary school (referred to as
‘‘basic’’), (2) apprenticeship ? secondary level (referred to
as ‘‘secondary’’) and (3) tertiary level, which included
university and other forms of education after the secondary
level (referred to as ‘‘university’’). Leisure-time physical
activity was considered when the participant reported
exercising at least once per week; no answer was considered
a negative answer. Smoking status was divided into current,
former (irrespective of the time since cessation) and never.
Statistical analysis
Statistical analysis was conducted using SAS v.9.2 (SAS
Inc., Cary, NC, USA). Quantitative variables were
expressed as mean ± standard deviation and qualitative
variables as number of participants and (percentage).
Bivariate comparisons were performed using Student’s
t test or a Chi-square test for quantitative and qualitative
variables, respectively.
The impact of nationality on the risk of presenting
CVRFs was assessed by multivariate logistic regression
analysis adjusting for gender, age, educational level, BMI
group and leisure-time physical activity. For the Swiss
Health Survey, a further adjustment on survey year was
applied. The effect of the length of residence was also
tested using categorical variables (1–9, 10–19, 20–29 and
30? years) and restricting the analyses to immigrant
groups. The results were expressed as odds ratio and 95%
confidence intervals. Statistically significant differences
were considered when p \ 0.05.
Results
Sample characteristics
From the initial 6,743 participants of the CoLaus study,
6,710 (91.5% 6,171 from the main study ? 539 non-Cau-
casians) had complete biological data and were included in
the analyses. Similarly, from the initial 49,261 participants
in the SHS, 49,245 (99.9%) had complete data for gender,
CVD risk factors in immigrants 65
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age and nationality and were included. Their clinical
characteristics according to nationality are summarised in
Tables 1 (SHS) and 2 (CoLaus Study). Participants from
southern Europe and the former Republic of Yugoslavia
were younger, had a lower educational level, engaged less
frequently in leisure-time physical activity and had lived in
Switzerland for a shorter time. Immigrants from France,
Portugal and Germany also presented lower obesity levels.
Finally, the proportions of women were lower among
immigrants from Italy, Spain and Former Yugoslavia.
Current smoking
In the SHS, participants from France, Italy, Portugal, Spain
and the former Republic of Yugoslavia had a higher
prevalence of smokers than Swiss nationals (Table 1). In
the CoLaus study, participants from France, Portugal and
the former Republic of Yugoslavia reported being smokers
than Swiss nationals, while a lower prevalence of smoking
was found for participants from Germany (Table 2).
Multivariate logistic regression analysis adjusting for
gender, age, educational level, BMI group and leisure-time
physical activity (and also survey year for SHS) showed
that participants from Portugal (and to a lesser degree
Spain and the rest of the world) were less likely to smoke,
while participants from the former Republic of Yugoslavia
were more likely to smoke when compared with Swiss
nationals (Table 3). Finally, no consistent relationship was
found between current smoking habits and the length of
residence (not shown).
Hypertension
In the SHS, participants from France, Portugal, Spain and the
former Republic of Yugoslavia reported less frequently
being told they were hypertensive than Swiss nationals.
Hypertensive subjects from Portugal and Spain and to a
lesser degree from the former Republic of Yugoslavia, Italy
and the rest of the world reported being treated less often than
Swiss nationals. Finally, participants from Portugal and
France reported a lower hypertension screening (Table 1).
In the CoLaus study, participants from France and
Portugal reported less frequently being told they were
hypertensive than Swiss nationals, while higher preva-
lences were found for participants from Germany and Italy.
Hypertensive participants from France and Portugal also
had lower treatment levels than Swiss nationals, whereas
no differences were found regarding blood pressure con-
trol. These findings were further confirmed using blood
pressure measurements; participants from France and
Portugal presented a lower prevalence of hypertension and
treatment, while participants from Italy had a higher
prevalence and were more frequently treated than Swiss
nationals (data not shown). Multivariate logistic regression
analysis showed that participants from France and Spain
(and to a lesser degree Portugal and the rest of the world)
had lower odds of presenting with hypertension when
compared with Swiss nationals. Regarding antihyperten-
sive treatment and blood pressure control, no consistent
difference was found between any of the nationalities
studied (Table 4). Finally, in the SHS, French immigrants
had lower odds than Swiss (OR = 0.68, 95% confidence
interval [0.51–0.92]) of having had their blood pressure
screened within the previous 12 months, while the opposite
trend was found for immigrants from other European
countries (OR = 1.35, [1.02–1.78]).
In the CoLaus study, the length of residence was posi-
tively related with both SBP (Spearman correlation =
0.235, N = 2626, p \ 0.001) and DBP (r = 0.080,
p \ 0.001), but this relationship was inverted after adjusting
for age (partial Spearman correlation = -0.041 and -0.048
for SBP and DBP, respectively, p \ 0.05). No significant
effect of the length of residence was found on hypertension
prevalence or treatment by multivariate logistic regression.
However, an increase in the likelihood of being treated was
found for subjects living in Switzerland longer than 30 years
in the SHS (OR = 3.55 [1.65–7.64]), but not in the CoLaus
study (OR = 0.84 [0.37–1.91]).
Dyslipidaemia
In the SHS, participants from southern Europe, the former
Republic of Yugoslavia, other European countries and the
rest of the world reported less frequently being told they
were dyslipidaemic than Swiss nationals. Participants from
France and Portugal also reported a lower screening for
dyslipidaemia (Table 1).
In the CoLaus study (restricted to Caucasian participants),
participants from France, Germany, the former Republic of
Yugoslavia, other European countries and the rest of the
world reported less frequently being told they were dyslipi-
daemic than Swiss nationals, while participants from Italy
reported more frequently being dyslipidaemic. After lipid
measurement and cardiovascular risk assessment, partici-
pants from France, Germany, Portugal, Spain, the former
Republic of Yugoslavia, other European countries and the
rest of the world were less eligible and participants from Italy
were more eligible for statin treatment than Swiss nationals
(not shown). Conversely, multivariate logistic regression
showed no consistent differences between nationalities
regarding the prevalence or treatment of dyslipidaemia
(Table 5). Finally, in the SHS, no differences were found
between immigrant groups and Swiss nationals regarding
high cholesterol screening (not shown).
In the CoLaus study, the length of residence was posi-
tively correlated with total cholesterol (Spearman
66 P. Marques-Vidal et al.
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correlation = 0.158, N = 2626, p \ 0.001), LDL-choles-
terol (r = 0.121, p \ 0.001) and triglyceride levels
(r = 0.121, p \ 0.001), but this relationship was abolished
after adjusting for age (partial Spearman correla-
tion = 0.019, 0.004 and 0.034 for total cholesterol, LDL-
cholesterol and triglycerides, respectively, p [ 0.05). No
relationship was found between the length of residence and
the prevalence of dyslipidaemia, while an increase in the
likelihood of being treated was found for subjects living in
Switzerland longer than 30 years in the SHS (OR = 4.24
[1.58–11.3]), but not in the CoLaus study (OR = 1.20
[0.51–2.85]).
Diabetes
In the SHS, participants from Germany, Portugal, the for-
mer Republic of Yugoslavia and the rest of the world
reported less frequently being told they were diabetic than
Swiss nationals. Participants from France, Portugal and
Spain also reported a lower diabetic screening (Table 1).
In the CoLaus study, participants from France, Portu-
gal, other European countries and the rest of the world
reported less frequently being told they were diabetic than
Swiss nationals, while the opposite was found for partic-
ipants from Italy and the former Republic of Yugoslavia.
Glucose measurements showed a lower prevalence of
diabetes among participants from France, Portugal and the
rest of the world, and a higher prevalence among partic-
ipants from Italy and the former Republic of Yugoslavia
(Table 2). Multivariate logistic regression showed no
consistent differences between nationalities regarding the
prevalence or treatment of diabetes (Table 6). Finally, in
the SHS, no differences were found between immigrants
and Swiss nationals regarding diabetes screening (data not
shown).
Discussion
To our knowledge, this is the most comprehensive study
assessing the prevalence of CVRFs according to nationality
among immigrants living in Switzerland. Overall, our data
suggest that CVRFs are unevenly distributed among
immigrants in Switzerland, but that these differences are
due mainly to disparities in age, leisure-time physical
activity, being overweight/obesity and socioeconomic sta-
tus. Indeed, the Swiss healthcare system has universal
health-insurance coverage. Though self-paid insurance fees
are high in Switzerland relative to other countries, the
existing regressive taxation and premium subsidies as well
as cost-sharing exemptions ensure that vulnerable groups
have good access to health care (OECD 2006).
Smoking
Contrary to previous findings (Gabadinho et al. 2007) but
in agreement with others (Koya and Egede 2007), a higher
prevalence of smoking was found among immigrants from
the former Republic of Yugoslavia. Conversely, no
Table 3 Multivariate analysis of the associations between nation-
ality and the prevalence of smoking for the Swiss Health Surveys
(SHS, 1997, 2002 and 2007) and the Cohorte Lausannoise (CoLaus)
study (2003–2006), adjusting for confounding variables
CoLaus SHS
Gender
Female 1 (ref.) 1 (ref.)
Male 0.71 [0.63–0.80] 0.59 [0.57–0.62]
Age groups
18–44 1 (ref.) 1 (ref.)
45–64 0.83 [0.73–0.94] 0.76 [0.72–0.79]
65? 0.49 [0.41–0.59] 0.27 [0.25–0.29]
Education
Basic 1 (ref.) 1 (ref.)
Secondary 0.83 [0.71–0.96] 0.90 [0.85–0.96]
University 0.55 [0.45–0.67] 0.68 [0.64–0.74]
BMI groupa
Normal 1 (ref.) 1 (ref.)
Overweight 0.69 [0.61–0.79] 0.77 [0.74–0.81]
Obese 0.50 [0.42–0.60] 0.74 [0.68–0.80]
Leisure-time PAb
No 1 (ref.) 1 (ref.)
Yes 0.62 [0.55–0.70] 0.71 [0.68–0.74]
Nationality
Swiss 1 (ref.) 1 (ref.)
German 0.87 [0.52–1.45] 1.04 [0.89–1.20]
Italian 0.91 [0.71–1.16] 0.96 [0.87–1.07]
French 1.10 [0.88–1.37] 1.19 [0.98–1.45]
Spanish 0.70 [0.52–0.95] 1.03 [0.83–1.26]
Portuguese 0.68 [0.52–0.88] 0.79 [0.66–0.96]
Former Yugoslaviac 0.92 [0.57–1.48] 1.50 [1.23–1.82]
Other, Europed 0.78 [0.62–0.97] 0.97 [0.85–1.12]
Other, world 0.91 [0.73–1.13] 0.64 [0.52–0.78]
Results are expressed as the odds ratio and [95% confidence interval].
Statistical analysis was by multivariate logistic regression. For the
SHS, a further adjustment on the survey was performed
BMI body mass index, PA physical activity
a Participants were considered to be of normal weight, overweight or
obese if their body mass index was \25, C25 and \30, and C30 kg/
m2, respectively
b Considered when the participant reported exercising at least once
per week
c Serbian, Croatian, Bosnian, Herzegovinan, Kosovan and
Macedonian
d Because of the small number of subjects, other nationalities were
grouped into either ‘‘Other, Europe’’ or ‘‘Other, world’’
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relationship was found between the length of residence and
smoking prevalence. It is possible that the comprehensive
tobacco prevention programme launched by the Swiss
Federal Office of Public Health (Office Fe´de´ral de la Sante´
Publique 2008) has been effective, as recent data indicate a
slight decrease in the prevalence of smoking in the Swiss
population (Marques-Vidal et al. 2010). Another explana-
tion is that older immigrants did not smoke before moving
to Switzerland, and they did not change their behaviours
after moving.
Hypertension
Immigrants from France and Southern Europe
(Spain ? Portugal) had lower levels of hypertension than
Swiss nationals, even after adjusting for confounding
Table 4 Multivariate analysis of the associations between nationality
and the prevalence and management of self-reported hypertension for
the Swiss Health Surveys (SHS, 1997, 2002 and 2007) and the
Cohorte Lausannoise (CoLaus) study (2003–2006), adjusting for
confounding variables
Prevalence Treatment
CoLaus, reported SHS CoLaus, reported SHS
Gender
Female 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.)
Male 0.79 [0.70–0.89] 0.96 [0.91–1.01] 1.04 [0.83–1.30] 1.20 [1.10–1.31]
Age groups
18–44 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.)
45–64 2.50 [2.11–2.96] 2.44 [2.30–2.58] 3.20 [2.31–4.44] 3.35 [3.00–3.76]
65? 5.40 [4.42–6.60] 6.32 [5.95–6.72] 7.51 [5.14–11.0] 9.31 [8.29–10.5]
Education
Basic 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.)
Secondary 0.98 [0.83–1.15] 0.90 [0.84–0.95] 0.89 [0.67–1.19] 0.98 [0.89–1.09]
University 0.76 [0.61–0.94] 0.85 [0.79–0.92] 0.64 [0.43–0.95] 1.00 [0.87–1.15]
BMI groupa
Normal 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.)
Overweight 2.11 [1.84–2.42] 2.02 [1.93–2.13] 1.59 [1.23–2.05] 1.48 [1.35–1.62]
Obese 4.95 [4.19–5.85] 4.16 [3.85–4.48] 2.34 [1.76–3.12] 2.09 [1.85–2.36]
Leisure-time PAb
No 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.)
Yes 0.86 [0.76–0.97] 0.89 [0.85–0.93] 0.87 [0.70–1.09] 0.86 [0.79–0.94]
Nationality
Swiss 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.)
German 1.63 [1.01–2.61] 0.86 [0.72–1.03] 1.27 [0.55–2.91] 1.08 [0.77–1.52]
Italian 1.06 [0.84–1.35] 0.96 [0.85–1.09] 1.49 [0.95–2.33] 0.59 [0.48–0.73]
French 0.79 [0.61–1.02] 0.67 [0.51–0.88] 0.77 [0.48–1.23] 1.37 [0.81–2.32]
Spanish 0.81 [0.60–1.11] 0.72 [0.54–0.96] 1.22 [0.67–2.19] 0.46 [0.25–0.83]
Portuguese 0.55 [0.40–0.76] 0.87 [0.67–1.12] 0.80 [0.44–1.44] 1.02 [0.61–1.69]
Former Yugoslaviac 1.12 [0.68–1.84] 0.97 [0.75–1.26] 1.38 [0.57–3.35] 0.98 [0.60–1.60]
Other, Europed 0.89 [0.70–1.13] 1.01 [0.85–1.19] 0.94 [0.61–1.45] 1.02 [0.75–1.39]
Other, world 0.68 [0.53–0.89] 0.93 [0.72–1.19] 0.89 [0.55–1.45] 1.39 [0.85–2.25]
Self-reported hypertension was defined as a positive answer to the question ‘‘Have you ever been told by a doctor that you have high blood
pressure (hypertension)?’’ Results are expressed as the odds ratio and [95% confidence interval]. Statistical analysis was by multivariate logistic
regression. For the SHS, a further adjustment on the survey was performed
BMI body mass index, PA, physical activity
a Participants were considered to be of normal weight, overweight or obese if their body mass index was \25, C25 and \30, and C30 kg/m2,
respectively
b Considered when the participant reported exercising at least once per week
c Serbian, Croatian, Bosnian, Herzegovinan, Kosovan and Macedonian
d Because of the small number of subjects, other nationalities were grouped into either ‘‘Other, Europe’’ or ‘‘Other, world’’
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factors. In agreement with a study conducted in the
Netherlands (Agyemang et al. 2005), no consistent dif-
ferences were found regarding HBP treatment between
immigrant groups relative to Swiss nationals. Some
studies have also suggested that hypertension control is
lower among immigrants (Agyemang et al. 2005; Verma
et al. 2010), but no such differences were found, again
suggesting that immigrants have the same access to health
care as the Swiss population. The higher likelihood of
being treated among immigrants living in Switzerland
longer than 30 years (SHS data) is in agreement with
other studies (Dias et al. 2008) and might be due to a
better knowledge of the health system by older immi-
grants. Still, no such relationship was found in the
Table 5 Multivariate analysis of the association between nationality
and the prevalence and management of self-reported dyslipidaemia
for the Swiss Health Surveys (SHS, 1997, 2002 and 2007) and the
Cohorte Lausannoise (CoLaus) study (2003–2006), adjusting for
confounding variables
Prevalence Treatment
CoLaus, reporteda SHS CoLaus, reporteda SHS
Gender
Female 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.)
Male 0.7 [0.62–0.8] 0.78 [0.74–0.83] 0.70 [0.56–0.88] 0.73 [0.65–0.81]
Age groups
18–44 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.)
45–64 2.74 [2.28–3.29] 2.84 [2.66–3.03] 3.62 [2.32–5.66] 2.36 [2.01–2.77]
65? 4.40 [3.55–5.45] 4.18 [3.90–4.48] 8.56 [5.30–13.8] 5.62 [4.78–6.60]
Education
Basic 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.)
Secondary 1.01 [0.85–1.20] 1.00 [0.93–1.07] 1.05 [0.78–1.42] 0.89 [0.78–1.02]
University 0.70 [0.55–0.88] 1.13 [1.04–1.23] 0.79 [0.52–1.22] 0.84 [0.70–1.00]
BMI groupb
Normal 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.)
Overweight 1.73 [1.50–1.99] 1.48 [1.40–1.56] 1.49 [1.16–1.93] 1.47 [1.31–1.64]
Obese 2.45 [2.06–2.91] 1.60 [1.47–1.75] 2.15 [1.59–2.89] 1.95 [1.66–2.29]
Leisure-time PAc
No 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.)
Yes 0.92 [0.81–1.04] 0.88 [0.84–0.93] 0.73 [0.58–0.92] 0.79 [0.71–0.88]
Nationality
Swiss 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.)
German 0.84 [0.49–1.44] 1.22 [1.02–1.46] 0.64 [0.23–1.80] 0.54 [0.36–0.82]
Italian 0.88 [0.69–1.13] 1.02 [0.89–1.17] 1.09 [0.71–1.68] 1.02 [0.77–1.36]
French 0.92 [0.71–1.20] 1.25 [0.98–1.61] 0.86 [0.55–1.36] 1.09 [0.65–1.84]
Spanish 0.89 [0.65–1.21] 0.93 [0.68–1.27] 1.16 [0.67–1.98] 0.49 [0.21–1.16]
Portuguese 1.13 [0.84–1.50] 1.31 [1.01–1.72] 0.66 [0.38–1.16] 0.77 [0.39–1.49]
Former Yugoslaviad 0.64 [0.36–1.15] 0.58 [0.40–0.83] 1.76 [0.63–4.89] 0.96 [0.42–2.16]
Other, Europee 0.85 [0.64–1.12] 0.99 [0.82–1.20] 1.00 [0.60–1.68] 0.91 [0.62–1.35]
Other, world 0.68 [0.43–1.08] 0.76 [0.56–1.03] 0.85 [0.34–2.13] 1.25 [0.63–2.50]
Self-reported dyslipidaemia was defined as a positive answer to the question ‘‘Have you ever been told by a doctor that you have high
cholesterol?’’ Results are expressed as the odds ratio and [95% confidence interval]. Statistical analysis was by multivariate logistic regression.
For the SHS, a further adjustment on the survey was performed
BMI body mass index, PA physical activity
a Caucasians only
b Participants were considered to be of normal weight, overweight or obese if their body mass index was\25, C25 and \30, and C30 kg/m2,
respectively
c Considered when the participant reported exercising at least once per week
d Serbian, Croatian, Bosnian, Herzegovinan, Kosovan and Macedonian
e Because of the small number of subjects, other nationalities were grouped into either ‘‘Other, Europe’’ or ‘‘Other, world’’
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CoLaus study, and further studies are needed to better
assess this issue.
Dyslipidaemia
Immigrants tended to present lower levels of dyslipidaemia
than Swiss nationals, but this difference was suppressed
after multivariate adjustment. These findings are in agree-
ment with the literature (Baron-Epel and Kaplan 2009; Bos
et al. 2004), suggesting that most differences in CVD risk
are due to socioeconomic variables and not to immigrant
status. Still, this last statement has been challenged (Ujcic-
Voortman et al. 2009), and some differences might be due
to differing genetic backgrounds.
Table 6 Multivariate analysis of the associations between nationality
and the prevalence and management of self-reported diabetes for the
Swiss Health Surveys (SHS, 1997, 2002 and 2007) and the Cohorte
Lausannoise (CoLaus) study (2003–2006), adjusting for confounding
variables
Prevalence Treatment
CoLaus, reported SHS CoLaus, reported SHS 2007
Gender
Female 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.)
Male 0.53 [0.41–0.67] 0.77 [0.70–0.85] 0.40 [0.20–0.82] 0.69 [0.51–0.93]
Age groups
18–44 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.)
45–64 2.72 [1.80–4.10] 2.41 [2.11–2.75] 1.13 [0.41–3.14] 2.69 [1.71–4.22]
65? 5.48 [3.52–8.54] 4.99 [4.38–5.68] 4.06 [1.2–13.71] 4.21 [2.74–6.46]
Education
Basic 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.)
Secondary 1.08 [0.79–1.47] 0.75 [0.67–0.83] 1.58 [0.66–3.75] 0.87 [0.60–1.26]
University 0.89 [0.57–1.40] 0.73 [0.63–0.85] 0.36 [0.11–1.13] 1.07 [0.68–1.70]
BMI group
Normal 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.)
Overweight 1.69 [1.22–2.34] 1.64 [1.48–1.82] 2.49 [1.06–5.85] 2.16 [1.55–3.00]
Obese 6.35 [4.63–8.73] 3.74 [3.31–4.23] 4.16 [1.81–9.58] 4.16 [2.81–6.16]
Leisure-time PA
No 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.)
Yes 0.52 [0.41–0.67] 0.73 [0.66–0.80] 0.89 [0.45–1.76] 0.72 [0.53–0.97]
Nationality
Swiss 1 (ref.) 1 (ref.) 1 (ref.) 1 (ref.)
German 1.43 [0.55–3.71] 0.76 [0.51–1.14] 0.90 [0.09–9.19] 0.47 [0.14–1.61]
Italian 1.21 [0.81–1.82] 1.01 [0.80–1.27] 0.57 [0.17–1.87] 1.02 [0.44–2.39]
French 1.00 [0.60–1.69] 0.82 [0.47–1.40] 0.34 [0.10–1.22] NA
Spanish 0.93 [0.52–1.68] 1.35 [0.83–2.20] 0.33 [0.09–1.29] 0.41 [0.07–2.50]
Portuguese 0.73 [0.39–1.37] 0.86 [0.49–1.52] 2.98 [0.29–30.4] 0.17 [0.02–1.59]
Former Yugoslaviac 1.44 [0.63–3.33] 0.82 [0.46–1.48] 1.24 [0.13–12.3] 0.52 [0.10–2.57]
Other, Europed 0.91 [0.55–1.49] 0.91 [0.64–1.31] 0.71 [0.18–2.82] 0.95 [0.31–2.94]
Other, world 0.50 [0.26–0.94] 1.02 [0.59–1.75] 0.33 [0.08–1.35] 0.90 [0.19–4.25]
Self-reported diabetes was defined as a positive answer to the question ‘‘Have you ever been told by a doctor that you have diabetes?’’ Results are
expressed as the odds ratio and [95% confidence interval]. Statistical analysis was by multivariate logistic regression. For the SHS, a further
adjustment on the survey was performed
BMI body mass index, PA physical activity, NA not assessable
a Participants were considered to be of normal weight, overweight or obese if their body mass index was\25, C25 and\30, and C30 kg/m2,
respectively
b Considered when the participant reported exercising at least once per week
c Serbian, Croatian, Bosnian, Herzegovinan, Kosovan and Macedonian
d Because of the small number of subjects, other nationalities were grouped into either ‘‘Other, Europe’’ or ‘‘Other, world’’
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A longer length of residence has also been shown to be
associated with an increased prevalence of dyslipidaemia
(Koya and Egede 2007). In this study, no such relationship
was found, while an increase in the likelihood of being
treated was found for subjects living in Switzerland longer
than 30 years (SHS data). With regard to hypertension,
these findings suggest that immigrants benefit from the
same access to health care as Swiss nationals.
Diabetes
Many studies indicate that Westernisation leads to increased
levels of diabetes (Gentilucci et al. 2008; Misra and Ganda
2007; Cappuccio et al. 1997), although this statement has
been challenged (Pollard et al. 2008). It has been suggested
that the difference in the prevalence of diabetes between
immigrants and nationals could be due partly to ethnicity
(Whitty et al. 1999). Still, in this study, no differences in the
prevalence of diabetes were found between immigrant
groups and Swiss nationals after adjusting for major con-
founders. Hence, as reported above, BMI and socioeconomic
factors might be more important than immigration status in
terms of the prevalence of diabetes.
There is some evidence supporting the claim that dia-
betic immigrants tend to be treated more often than local
nationals (Tran et al. 2010; Verma et al. 2010). In this
study, however, no such relationship was found, but the
number of subjects was very small, precluding a precise
assessment. Still, no differences were found for diabetes
screening, suggesting that immigrants might benefit from
the same access to health care as Swiss nationals.
Limitations
This study has several limitations worth noting. The par-
ticipation rate in the CoLaus study was low (41%), which
might limit the generalisation of the findings; however, this
participation rate is similar to other epidemiological studies
(Grøtvedt et al. 2008). Secondly, it has been shown that
SCORE performs differently according to ethnicity (Kumar
et al. 2009). Although risk calculators that take ethnicity
into account had been developed (Brindle et al. 2006), it
was not possible to precisely assess the ethnicity of all the
CoLaus and SHS participants. Hence, in agreement with
current ESC guidelines (Graham et al. 2007), it was deci-
ded to use a single, country-calibrated equation (Marques-
Vidal et al. 2008). Further, the SHS only assessed subjects
with fixed telephone lines, leading to a possible selection
bias as no data could be obtained from subjects who only
possess mobile phones. To our knowledge, there are no
data in Switzerland which might enable to assess the
characteristics of the subjects who tend to prefer mobile to
fixed phones, so correction is difficult. Still, according to
the Federal Office of Statistics, Switzerland has one of
the highest fixed line rates among industrialised countries
(http://www.bfs.admin.ch/bfs/portal/fr/index/themen/16/04/
key/approche_globale.Document.25543.xls), so this bias
might be less important than for other countries. Height
and weight were self-reported in the SHS, leading to an
underestimation of obesity prevalence. This might partly
explain the lower odds ratios for obesity observed in the
SHS, as some obese subjects were misclassified as over-
weight and some overweight subjects were misclassified as
normal weight, thus decreasing the association between
BMI categories and CVRFs. The major strength of our
study was that we used two population-based samples
representative of the Swiss population, and that the results
obtained were quite similar.
A possible explanation for the lower prevalence of some
CVRFs among immigrants might be due to maintenance of
their original dietary practices, as it has been showed that a
Mediterranean diet is protective towards CVD (Sofi et al.
2010). Still, recent data (Bach-Faig et al. 2011; Baldini
et al. 2009; Chen and Marques-Vidal 2007) suggest that
this dietary pattern is being progressively abandoned, and it
would be of interest to assess dietary intake among
immigrants and Swiss nationals.
In summary, our results indicate that most CVRFs are
unevenly distributed among immigrants in Switzerland, but
that these differences are due mainly to disparities in age,
leisure-time physical activity, BMI and socioeconomic
status. Management of CVRFs does not seem to differ
between immigrant groups and Swiss nationals, suggesting
that these groups have equal access to health care.
Acknowledgments The CoLaus study was supported by research
grants from GlaxoSmithKline, the Faculty of Biology and Medicine
of Lausanne, Switzerland and the Swiss National Science Foundation
(Grant no: 33CSCO-122661). The authors also express their gratitude
to the participants in the Lausanne CoLaus study and to the investi-
gators who have contributed to the recruitment, in particular Yolande
Barreau, Anne-Lise Bastian, Binasa Ramic, Martine Moranville,
Martine Baumer, Marcy Sagette, Jeanne Ecoffey and Sylvie Mer-
moud for data collection.
References
Agyemang C, Bindraban N, Mairuhu G, Montfrans G, Koopmans R,
Stronks K (2005) Prevalence, awareness, treatment, and control
of hypertension among Black Surinamese, South Asian Suri-
namese and White Dutch in Amsterdam, The Netherlands: the
SUNSET study. J Hypertens 23:1971–1977
Anonymous (2008) Diagnosis and classification of diabetes mellitus.
Diabetes Care 31(Suppl 1): S55–S60. doi:10.2337/dc08-S055
Bach-Faig A, Fuentes-Bol C, Ramos D, Carrasco JL, Roman B,
Bertomeu IF, Cristia` E, Geleva D, Serra-Majem L (2011) The
Mediterranean diet in Spain: adherence trends during the past
two decades using the Mediterranean Adequacy Index. Public
Health Nutr 14:622–628. doi:10.1017/S1368980010002752
CVD risk factors in immigrants 75
123
Bainey KR, Jugdutt BI (2009) Increased burden of coronary artery
disease in South-Asians living in North America. Need for an
aggressive management algorithm. Atherosclerosis 204:1–10.
doi:10.1016/j.atherosclerosis.2008.09.023
Baldini M, Pasqui F, Bordoni A, Maranesi M (2009) Is the
Mediterranean lifestyle still a reality? Evaluation of food
consumption and energy expenditure in Italian and Spanish
university students. Public Health Nutr 12:148–155. doi:
10.1017/S1368980008002759
Baron-Epel O, Kaplan G (2009) Can subjective and objective
socioeconomic status explain minority health disparities in
Israel? Soc Sci Med 69:1460–1467. doi:10.1016/j.socscimed.
2009.08.028
Bischoff A, Wanner P (2008) The self-reported health of immigrant
groups in Switzerland. J Immigr Minor Health 10:325–335. doi:
10.1007/s10903-007-9089-z
Bos V, Kunst AE, Keij-Deerenberg IM, Garssen J, Mackenbach JP
(2004) Ethnic inequalities in age- and cause-specific mortality in
The Netherlands. Int J Epidemiol 33:1112–1119. doi:10.1093/
ije/dyh189
Brindle P, May M, Gill P, Cappuccio F, D’Agostino R Sr,
Fischbacher C, Ebrahim S (2006) Primary prevention of
cardiovascular disease: a web-based risk score for seven British
black and minority ethnic groups. Heart 92:1595–1602. doi:
10.1136/hrt.2006.092346
Calmonte R, Galati-Petrecca M, Lieberherr R, Neuhaus M, Kahlmeier
S (2005) Gesundheit und Gesundheitsverhalten in der Schweiz
1992–2002. Schweizerische Gesundheitsbefragung. Neuchaˆtel,
Swiss Federal Statistical Office, Switzerland, p 100. ISBN:
3-303-14090-1
Cappuccio FP, Cook DG, Atkinson RW, Strazzullo P (1997)
Prevalence, detection, and management of cardiovascular risk
factors in different ethnic groups in south London. Heart
78:555–563
Carrasco-Garrido P, de Miguel AG, Barrera VH, Jime´nez-Garcia R
(2007) Health profiles, lifestyles and use of health resources by
the immigrant population resident in Spain. Eur J Public Health
17:503–507. doi:10.1093/eurpub/ckl279
Chen Q, Marques-Vidal P (2007) Trends in food availability in
Portugal in 1966–2003: comparison with other Mediterranean
countries. Eur J Nutr 46:418–427. doi:10.1007/s00394-007-
0681-8
Conroy RM, Pyo¨ra¨la¨ K, Fitzgerald AP, Sans S, Menotti A, De Backer
G, De Bacquer D, Ducimetie`re P, Jousilahti P, Keil U, Njolstad
I, Oganov RG, Thomsen T, Tunstall-Pedoe H, Tverdal A, Wedel
H, Whincup P, Wilhelmsen L, Graham IM (2003) Estimation of
ten-year risk of fatal cardiovascular disease in Europe: the
SCORE project. Eur Heart J 24:987–1003
Dias SF, Severo M, Barros H (2008) Determinants of health care
utilization by immigrants in Portugal. BMC Health Serv Res
8:207. doi:10.1186/1472-6963-8-207
Firmann M, Mayor V, Marques-Vidal P, Bochud M, Pe´coud A,
Hayoz D, Paccaud F, Preisig M, Song KS, Yuan X, Danoff TM,
Stirnadel HA, Waterworth DM, Mooser V, Waeber G, Vol-
lenweider P (2008) The CoLaus study: a population-based study
to investigate the epidemiology and genetic determinants of
cardiovascular risk factors and metabolic syndrome. BMC
Cardiovasc Disord 8:6
Gabadinho A, Wanner P, Dahinden J (2007) La sante´ des populations
migrantes en Suisse: une analyse des donne´es du GMM [Health
of migrants in Switzerland: analysis of the GMM data]. Swiss
Forum Migr Stud (Neuchaˆtel, Switzerland) 49:1–90. ISBN:978-
2-940379-07-1
Gadd M, Johansson SE, Sundquist J, Wandell P (2003) Morbidity in
cardiovascular diseases in immigrants in Sweden. J Intern Med
254:236–243
Gentilucci UV, Picardi A, Manfrini S, Khazrai YM, Fioriti E,
Altomare M, Guglielmi C, Di Stasio E, Pozzilli P (2008)
Westernization of the Filipino population resident in Rome:
obesity, diabetes and hypertension. Diabetes Metab Res Rev
24:364–370. doi:10.1002/dmrr.807
Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R,
Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B,
Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk
J, Priori SG, Pyo¨ra¨la¨ K, Reiner Z, Ruilope L, Sans-Menendez S,
Op Reimer WS, Weissberg P, Wood D, Yarnell J, Zamorano JL,
Walma E, Fitzgerald T, Cooney MT, Dudina A, Vahanian A,
Camm J, De Caterina R, Dean V, Dickstein K, Funck-Brentano
C, Filippatos G, Hellemans I, Kristensen SD, McGregor K,
Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL,
Altiner A, Bonora E, Durrington PN, Fagard R, Giampaoli S,
Hemingway H, Hakansson J, Kjeldsen SE, Larsen ML, Mancia
G, Manolis AJ, Orth-Gomer K, Pedersen T, Rayner M, Ryden L,
Sammut M, Schneiderman N, Stalenhoef AF, Tokgozoglu L,
Wiklund O, Zampelas A (2007) European guidelines on
cardiovascular disease prevention in clinical practice: executive
summary. Fourth Joint Task Force of the European Society of
Cardiology and other societies on cardiovascular disease
prevention in clinical practice (constituted by representatives
of nine societies and by invited experts). Eur J Cardiovasc Prev
Rehabil 14(Suppl 2):E1–E40. doi:10.1097/01.hjr.0000277984.
31558.c4
Grøtvedt L, Kuulasmaa K, Tolonen H, Heldal J, Graff-Iversen S
(2008) Sampling and recruitment. In: Tolonen H, Koponen P,
Aromaa A, Conti S, Graff-Iversen S et al (eds) Review of health
examination surveys in Europe. KTL, National Public Health
Institute, Helsinki, pp 82–126
IHA-GfK (2003) Schweizerische Gesundheitsbefragung SGB 2002—
Schlussbericht zur Datenerhebung. Neuchaˆtel, Swiss Federal
Statistical Office, Switzerland
Kouris-Blazos A (2002) Morbidity mortality paradox of 1st gener-
ation Greek Australians. Asia Pac J Clin Nutr 11(Suppl 3):S569–
S575
Koya DL, Egede LE (2007) Association between length of residence
and cardiovascular disease risk factors among an ethnically
diverse group of United States immigrants. J Gen Intern Med
22:841–846. doi:10.1007/s11606-007-0163-y
Kumar BN, Selmer R, Lindman AS, Tverdal A, Falster K, Meyer HE
(2009) Ethnic differences in SCORE cardiovascular risk in Oslo,
Norway. Eur J Cardiovasc Prev Rehabil 16:229–234. doi:
10.1097/HJR.0b013e3283294b07
Marques-Vidal P, Rodondi N, Bochud M, Pe´coud A, Hayoz D,
Paccaud F, Mooser V, Waeber G, Vollenweider P (2008)
Predictive accuracy and usefulness of calibration of the ESC
SCORE in Switzerland. Eur J Cardiovasc Prev Rehabil
15:402–408. doi:10.1097/HJR.0b013e3282fb040f
Marques-Vidal P, Cerveira J, Paccaud F, Cornuz J (2010) Smoking trends
in Switzerland, 1992–2007: a time for optimism? J Epidemiol
Community Health 65:281–286. doi:10.1136/jech.2009.099424
Misra A, Ganda OP (2007) Migration and its impact on adiposity and
type 2 diabetes. Nutrition 23:696–708. doi:10.1016/j.nut.
2007.06.008
OECD (19-10-2006) OECD Reviews of Health Systems—Switzer-
land. Organisation of Economic Co-operation and Development,
Paris
Office Fe´de´ral de la Sante´ Publique (2008) Dossier sur la politique en
matie`re de tabagisme dans les cantons et en Europe. Etat au 1er
Janvier 2008. 1–24
Office Fe´de´ral des Migrations (ODM) (2010) Rapport sur la migration
2009. 1–50
Pollard TM, Unwin N, Fischbacher C, Chamley JK (2008) Differ-
ences in body composition and cardiovascular and type 2
76 P. Marques-Vidal et al.
123
diabetes risk factors between migrant and British-born British
Pakistani women. Am J Hum Biol 20:545–549. doi:10.1002/
ajhb.20773
Sofi F, Abbate R, Gensini GF, Casini A (2010) Accruing evidence on
benefits of adherence to the Mediterranean diet on health: an
updated systematic review and meta-analysis. Am J Clin Nutr
92:1189–1196. doi:10.3945/ajcn.2010.29673
Tran AT, Diep LM, Cooper JG, Claudi T, Straand J, Birkeland K,
Ingskog W, Jenum AK (2010) Quality of care for patients with
type 2 diabetes in general practice according to patients’ ethnic
background: a cross-sectional study from Oslo, Norway. BMC
Health Serv Res 10:145. doi:10.1186/1472-6963-10-145
Ujcic-Voortman JK, Schram MT, Jacobs-van der Bruggen MA,
Verhoeff AP, Baan CA (2009) Diabetes prevalence and risk
factors among ethnic minorities. Eur J Public Health
19:511–515. doi:10.1093/eurpub/ckp096
Verma A, Birger R, Bhatt H, Murray J, Millett C, Saxena S, Banarsee
R, Gnani S, Majeed A (2010) Ethnic disparities in diabetes
management: a 10-year population-based repeated cross-sec-
tional study in UK primary care. J Public Health (Oxf)
32:250–258. doi:10.1093/pubmed/fdp114
Wanner P, Bouchardy C, Raymond L (2000) Mortalite´ des e´trangers
en Suisse: analyse par grand groupe de causes et par type de
cancer, 1989–1992
Whitty CJ, Brunner EJ, Shipley MJ, Hemingway H, Marmot MG
(1999) Differences in biological risk factors for cardiovascular
disease between three ethnic groups in the Whitehall II Study.
Atherosclerosis 142:279–286
CVD risk factors in immigrants 77
123
